| Round | Date | Amount |
|---|---|---|
| — | 2026-11-13 | $84M |
<a href="https://steek.live/companies/3701"><img src="https://api.steek.live/scoreboard/company/3701/badge.svg" alt="Steek Score" width="248" height="64" /></a>| Company | Raised | Score |
|---|---|---|
| Candid Health Candid Health builds automated healthcare revenue cycle management and medical billing software that helps medical groups, digital health companies, and billing teams submit claims, reduce denials, and accelerate insurance reimbursement workflows. | $120M | 64 |
| Avante | $30M | 59 |
| Forus | $3.0B | 53 |
| Suki | $90M | 53 |
| October 31 | $171M | 53 |
| Confido Health | $13M | 52 |
| November 07 | $290M | 52 |
| Savory | $202M | 51 |
| Midstream Health | $20M | 49 |
| HealthLeap | $38M | 48 |
VectorY Therapeutics has a Steek Score of 58 (Emerging) — a transparent 0–100 momentum index built from funding, traction and attention signals.
VectorY Therapeutics operates in healthcare ai, where it ranks #3 of 74 by Steek Score.
VectorY Therapeutics has raised $84M (2026-11-13).
Top competitors include Candid Health, Avante, Forus.
Steek Score is a transparent momentum index computed from tracked public signals. Not investment advice.